PACB icon

Pacific Biosciences

225 hedge funds and large institutions have $1.23B invested in Pacific Biosciences in 2022 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 64 increasing their positions, 67 reducing their positions, and 40 closing their positions.

Holders
225
Holders Change
-2
Holders Change %
-0.88%
% of All Funds
3.89%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.05%
New
39
Increased
64
Reduced
67
Closed
40
Calls
$11.6M
Puts
$20M
Net Calls
-$8.32M
Net Calls Change
-$6.52M
Name Market Value Shares Shares
Change
Shares
Change %
SOW
251
State of Wyoming
Wyoming
-463 Closed
GWM
252
Geneos Wealth Management
Colorado
-240 Closed
GWMIA
253
Global Wealth Management Investment Advisory
Florida
-135 Closed
CWP
254
Concord Wealth Partners
Virginia
-93 Closed
EI
255
Ellevest Inc
New York
-70 Closed
Northwestern Mutual Wealth Management
256
Northwestern Mutual Wealth Management
Wisconsin
-5 Closed
C
257
Covestor
United Kingdom
$0 24 -4 -14%
CCM
258
Cinctive Capital Management
New York
SN
259
Sittner & Nelson
Oregon
$0 60
PA
260
Parallel Advisors
California
$0 46
Balyasny Asset Management
261
Balyasny Asset Management
Illinois
PVI
262
Pura Vida Investments
New York
BTI
263
Blue Trust Inc
Georgia
$0 49
Simplex Trading
264
Simplex Trading
Illinois
CM
265
Caption Management
Oklahoma
Walleye Trading
266
Walleye Trading
New York
Group One Trading
267
Group One Trading
Illinois
Man Group
268
Man Group
United Kingdom
PNC Financial Services Group
269
PNC Financial Services Group
Pennsylvania
$0 64
HFS
270
Hantz Financial Services
Michigan
$0 4
GI
271
Gradient Investments
Minnesota
$0 60
HNB
272
Huntington National Bank
Ohio
$0 1
BIA
273
Bell Investment Advisors
California
$0 86 +86 New